论文部分内容阅读
TNNI3K is a MAP kinase specifically and continuously expressed in cardiac muscle and interacted with cardiac troponin Ⅰ (TNNI3, or cTnI).The aim of this study is to investigate role of TNNI3K interacting with cTnI in modification of the physiological function of cardiomyocytes and suppression of some pathological injuries and to explain the new molecular mechanism for TNNI3K-mutant in the ischemic coronary heart diseases, and hope to develop some new therapeutic strategies.